241. Early switch from intravenous to oral antibiotics in patients with Gram-negative bacteremia – a target trial emulation

BACKGROUND: Gram-negative bacteremia is a global health concern, that continues to cause significant morbidity and mortality. Intravenous (IV) antibiotics are typically the first-line treatment; however, it is unclear when it is appropriate to switch to oral antibiotics in order to maintain positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Tingsgård, Sandra, Bastrup Israelsen, Simone, Østergaard, Christian, Benfield, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678481/
http://dx.doi.org/10.1093/ofid/ofad500.314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678481/
http://dx.doi.org/10.1093/ofid/ofad500.314

Ejemplares similares